Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Chi Lin

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Anti-Cancer Drugs|September 1, 2007
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinomaChia-Chi Lin, Kun-Huei Yeh, Chih-Hsin Yang, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Enzyme and Microbial Technology|March 20, 2016
Enhanced bioconversion rate and released substrate inhibition in (R)-phenylephrine whole-cell bioconversion via partial acetone treatmentShu-Chen Kan, Chi-Zong Zang, Chiung-Wen Yeh, et al.
ACS Applied Materials & Interfaces|December 12, 2022
Solution-Processed Isoindigo- and Thienoisoindigo-Based Donor-Acceptor-Donor π-Conjugated Small Molecules: Synthesis, Morphology, Molecular Packing, and Field-Effect Transistor CharacterizationYu-Ting Liao, Yi-Chun Hsiao, Yuan-Chih Lo, et al.
Journal of Cancer Research and Clinical Oncology|August 25, 2021
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapyTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 31, 2016
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvementYun Chiang, Jason Chia-Hsien Cheng, Chao-Yuan Huang, et al.
Urologic Oncology|February 23, 2013
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancerMatthew D Galsky, Susan Krege, Chia-Chi Lin, et al.
Organic Letters|January 16, 2014
Practical synthesis of N-substituted cyanamides via Tiemann rearrangement of amidoximesChia-Chi Lin, Tsung-Han Hsieh, Pen-Yuan Liao, et al.
Thoracic Cancer|June 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancerJhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh, et al.
Anti-Cancer Drugs|March 14, 2007
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II studyChia-Chi Lin, Chih-Hung Hsu, Chao-Yuan Huang, et al.
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Anti-Cancer Drugs|September 1, 2007
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinomaChia-Chi Lin, Kun-Huei Yeh, Chih-Hsin Yang, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Enzyme and Microbial Technology|March 20, 2016
Enhanced bioconversion rate and released substrate inhibition in (R)-phenylephrine whole-cell bioconversion via partial acetone treatmentShu-Chen Kan, Chi-Zong Zang, Chiung-Wen Yeh, et al.
ACS Applied Materials & Interfaces|December 12, 2022
Solution-Processed Isoindigo- and Thienoisoindigo-Based Donor-Acceptor-Donor π-Conjugated Small Molecules: Synthesis, Morphology, Molecular Packing, and Field-Effect Transistor CharacterizationYu-Ting Liao, Yi-Chun Hsiao, Yuan-Chih Lo, et al.
Journal of Cancer Research and Clinical Oncology|August 25, 2021
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapyTa-Chen Huang, Cher-Wei Liang, Yu-I Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 31, 2016
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvementYun Chiang, Jason Chia-Hsien Cheng, Chao-Yuan Huang, et al.
Urologic Oncology|February 23, 2013
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancerMatthew D Galsky, Susan Krege, Chia-Chi Lin, et al.
Organic Letters|January 16, 2014
Practical synthesis of N-substituted cyanamides via Tiemann rearrangement of amidoximesChia-Chi Lin, Tsung-Han Hsieh, Pen-Yuan Liao, et al.
Thoracic Cancer|June 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancerJhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh, et al.
Anti-Cancer Drugs|March 14, 2007
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II studyChia-Chi Lin, Chih-Hung Hsu, Chao-Yuan Huang, et al.
Pageof 24